Research

Written on .

Progress in the fight against cancer diseases depends, first and foremost, on the constant and increasingly close interaction between treatment and translational research activities. For this reason, IRST works to strengthen scientific

research: basic, epidemiological, preclinical, clinical, and organisational. To give substance to its mission IRST promotes scientific collaborations with Universities, IRCCS, Institutions, and some of the most important national and international centres of oncological research and treatment.
 
Organisational Model and Research Lines
Over the years, Scientific Management has pursued the strengthening of the Technical Structure, in particular: 
  • the Grant Office with the gradual increase of facilitation, support, networking, internationalisation, and application to competitive calls; 
  • Technology Transfer;
  • the Biostatistics Facility, which progressively implemented support for Phase 1 trials;
  • Research platforms such as the Bioscience Laboratory, the Biological Resource Centre, the Animal facility and the Genomic facility.

NATIONAL AND INTERNATIONAL NETWORKS

IRST constantly invests in networking and internationalisation activities with the specific aim of exchanging and sharing individual research projects, In this way, relationships have been consolidated between the world of research, institutions, bodies, and companies in the area, while at the same time helping to expand the Institute's knowledge abroad. The consolidation and expansion of relations with European institutions, and other key players in the decision-making process (Ministries, the European Commission, Liaison Offices, European Networks, and umbrella organisations active in the field of R&I) are vital for the Grant Office. In 2021, relations were also consolidated through bilateral contacts and meetings as well as through multilateral networks.
 
Regional level
  • Membership of CLUST-ER Health and Wellness Industries;
  • Rete Alta Tecnologia (RAT);
  • ConfIndustria Emilia-Romagna;
  • UniIndustria Forlì-Cesena, where IRST represents the Health sector, in conjunction with local companies;
  • IRST maintains relations with ASTER offices in Brussels with a direct monitoring action; participation in INTERREG-ELISE call as a stakeholder for technology transfer of the Emilia-Romagna Region.
 
National and International level
  • Network Alliance Against Cancer (ACC).
 
 European Research Infrastructures
  • EATRIS European Advanced Translational Research Infrastructure;
  • ECRIN European Clinical Research Infrastructures Network;
  • BBMRI Biobanking and Biomolecular Resources Research Infrastructure;
  • EURACAN European Rare Cancer Network
  • ERN European Reference Network (ERN);
  • APRE - Agency for the Promotion of European Research; 
  • Active participation in ICPerMed (International Consortium for Personalised Medicine);
  • Active participation in REGIONS4PERMED - 'INTERREGIONAL COORDINATION FOR A FAST AND DEEP UPTAKE OF PERSONALISED HEALTH';
  • Active participation in 1 Million Genomes (1MG);
  • Active participation in Big Data Association;
  • Active participation in Health Big Data, coordinated by ACC. 

TECHNOLOGY TRANSFER

Technology transfer is the process by which knowledge, techniques, production methods, prototypes, and services that have been developed by research institutions are made accessible to a wide range of users. It is therefore part of open innovation since ensuring that scientific and technological developments are accessible to others who can then further develop and exploit the technology into new products, processes, applications, materials, or services.
IRST actively participates in the open innovation process by transferring the knowledge gained from the world of scientific research to the market, making it accessible to civil society, in line with the institutional mission oriented towards the valorisation of research.